Actively Recruiting
Effects of Kneipp Hydrotherapy in Post-COVID-19 Patients
Led by Eggensberger OHG · Updated on 2025-12-02
30
Participants Needed
1
Research Sites
99 weeks
Total Duration
On this page
Sponsors
E
Eggensberger OHG
Lead Sponsor
B
Bavarian Health and Food Safety Authority (LGL)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This randomized controlled study evaluates the effects of cold water hydrotherapy in patients with Post-COVID Syndrome. The primary aim is to assess changes in quality of life compared to an usual care setting without hydrotherapy treatment.
CONDITIONS
Official Title
Effects of Kneipp Hydrotherapy in Post-COVID-19 Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of Post-COVID Syndrome (ICD-10 code: U08.9)
- Barthel-Index greater than 80
- Own a smartphone to receive digital questionnaires and use the heart rate variability app
- Provide written informed consent
You will not qualify if you...
- Severe cardiovascular diseases such as decompensated heart failure, unstable angina pectoris, or acute myocardial infarction
- Severe venous diseases like acute deep vein thrombosis of the leg
- Severe neurological diseases including uncontrolled epilepsy
- Prior regular practice of Kneipp hydrotherapy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Eggensberger Ohg
Füssen, Bavaria, Germany, D-87629
Actively Recruiting
Research Team
A
Andreas Eggensberger, MSc
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here